Results 191 to 200 of about 162,637 (248)

Real-world clinical insights and aqueous humor biomarker analysis of diabetic macular edema subtypes classified by OCT following intravitreal injections. [PDF]

BMC Ophthalmol
Tan L, Liu S, Linghu W, Ke Y, Li Y, Pazo EE, Ren X.   +6 more
europepmc   +1 more source

Intravitreal Injections of Cord Blood Platelet-Rich Plasma in Dry Age-Related Macular Degeneration: Regenerative Therapy. [PDF]

Ophthalmol Sci
Savastano MC, Fossataro C, Berni A, Savastano A, Cestrone V, Giannuzzi F, Boselli F, Carlà MM, Cusato M, Mottola F, Pirolo R, D'Agostino E, Biagini I, Marcelli S, Gravina A, Shen M, Rizzo C, Valentini CG, Bianchi M, Teofili L, Cheng Y, Wang RK, Rosenfeld PJ, Rizzo S.   +23 more
europepmc   +1 more source

Factors determining compliance with recommended intravitreal injections for retinal diseases among out-of-pocket, fully subsidized (non-paying), and insured patients: Real-world evidence from India. [PDF]

Indian J Ophthalmol
Das AV, Kashyap B, Takkar B, Venugopal R, Chatterjee C, Mehta MC, Stewart MW, Murthy GVS, Khanna RC, Das T, Narayanan R.   +10 more
europepmc   +1 more source

Acceptance of the Disease in Patients Diagnosed with Neovascular Age-Related Macular Degeneration Depending on Visual Parameters-Before and After a Series of Seven Intravitreal Injections. [PDF]

J Clin Med
Nowak M, Cybulska AM, Schneider-Matyka D, Grochans E, Walaszek I, Panczyk M, Nowicki GJ, Rachubińska K.   +7 more
europepmc   +1 more source

Macular edema in Wyburn-Mason syndrome: Resolution with anti-VEGF intravitreal injections. Case report and review of the literature. [PDF]

Am J Ophthalmol Case Rep
Hupin N, Cahill T, Boschi A, Kozyreff A.
europepmc   +1 more source

Intravitreal injection technique.

Community eye health, 2015
openaire   +1 more source

Complications of intravitreal injections

Current Opinion in Ophthalmology, 2010
Over the past few years, the results of many studies have highlighted the risks and benefits of intravitreal injection of a number of medications, the most common being triamcinolone, antivascular endothelial growth factor (VEGF) agents, antibiotics, antivirals, antifungals, and methotrexate. The purpose of this review is to highlight the complications
Sampat, Kapil M., Garg, Sunir J.
core   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Endophthalmitis following intravitreal injections

Graefe's Archive for Clinical and Experimental Ophthalmology, 2011
To report the clinical features, culture results, management and visual outcome of patients with endophthalmitis following intravitreal injections.Retrospective review of all patients with suspected endophthalmitis after intravitreal injections treated with intravitreal antibiotics (teicoplanin and ciprofloxacin) at a referral centre between January ...
Heinrich Heimann
exaly   +3 more sources

Scleral Thinning After Repeated Intravitreal Injections of Antivascular Endothelial Growth Factor Agents in the Same Quadrant [PDF]

, 2015
PURPOSE We assessed the effects of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy on scleral architecture using spectral domain anterior segment optical coherence tomography (OCT).
Andreas Ebneter, Martin Zinkernagel, Sebastian Wolf   +2 more
exaly   +2 more sources

Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis

Clinical Ophthalmology, 2015
Douglas K Sigford,1 Shivani Reddy,1 Christine Mollineaux,2 Shlomit Schaal1 1Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, 2Department of Ophthalmology and Visual Science, University of Kentucky, Lexington ...
Shlomit Schaal
exaly   +1 more source